Nerio
Boehringer Ingelheim Acquires Nerio Therapeutics for $1.3 Billion, Expanding Immuno-Oncology Portfolio
Boehringer Ingelheim, Nerio Therapeutics, Immuno-Oncology, Cancer Treatment, Acquisition, Small Molecule Inhibitors
Actionable Insights Powered by AI
Boehringer Ingelheim, Nerio Therapeutics, Immuno-Oncology, Cancer Treatment, Acquisition, Small Molecule Inhibitors